National drug control strategy. Overview briefing

LDR 01569nas a2200361 a 4500
001 003497211
003 MiAaHDL
005 20230725000000.0
006 m d
007 cr bn ---auaua
008 000814c199u9999dcuar f0 0eng d
010 ⊔ ⊔ ‡asn 99034580
035 ⊔ ⊔ ‡a(MiU)990034972110106381
035 ⊔ ⊔ ‡asdr-miu.990034972110106381
035 ⊔ ⊔ ‡z(MiU)MIU01000000000000003497211-goog
035 ⊔ ⊔ ‡a(OCoLC)41622894
035 ⊔ ⊔ ‡z(MiU)Aleph003497211
040 ⊔ ⊔ ‡aCUY ‡cCUY ‡dIUL ‡dEYM
042 ⊔ ⊔ ‡alcd
043 ⊔ ⊔ ‡an-us---
050 ⊔ 4 ‡aHV5825 ‡b.N3333
074 ⊔ ⊔ ‡a0859-R-03
086 0 ⊔ ‡aPREX 26.1/2: OVER/
110 1 ⊔ ‡aUnited States. ‡bOffice of National Drug Control Policy.
245 1 0 ‡aNational drug control strategy. ‡pOverview briefing.
246 3 0 ‡aOverview briefing
260 ⊔ ⊔ ‡aWashington, D.C. : ‡bExecutive Office of the President, Office of National Drug Control Policy,
300 ⊔ ⊔ ‡av. ; ‡c28 cm.
310 ⊔ ⊔ ‡aAnnual
500 ⊔ ⊔ ‡aDescription based on: 1999; title from cover.
538 ⊔ ⊔ ‡aMode of access: Internet.
580 ⊔ ⊔ ‡aCompanion volume to: United States. Office of National Drug Control Policy. National drug control strategy.
650 ⊔ 0 ‡aDrug abuse ‡zUnited States ‡xPrevention ‡vPeriodicals.
650 ⊔ 0 ‡aDrug control ‡zUnited States ‡vPeriodicals.
780 0 0 ‡aUnited States. Office of National Drug Control Policy. ‡tNational drug control strategy. Executive overview ‡w(DLC) 98645456 ‡w(OCoLC)36849921
787 1 ⊔ ‡aUnited States. Office of National Drug Control Policy. ‡tNational drug control strategy ‡w(DLC) 93650296 ‡w(OCoLC)23250708
899 ⊔ ⊔ ‡a39015078415307 ‡bBuhr B 1906493 ‡c1999
CID ⊔ ⊔ ‡a003497211
DAT 0 ⊔ ‡a20000814000000.0 ‡b20230725000000.0
DAT 1 ⊔ ‡a20230725060823.0 ‡b2023-07-25T18:27:32Z
DAT 2 ⊔ ‡a2023-02-04T18:30:03Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-008
FMT ⊔ ⊔ ‡aSE
HOL ⊔ ⊔ ‡0sdr-miu.990034972110106381 ‡aMiU ‡bSDR ‡cMIU ‡f003497211 ‡pmdp.39015078415307 ‡sMIU ‡z1999 ‡1990034972110106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20230725 ‡sgoogle ‡umdp.39015078415307 ‡z1999 ‡y1999 ‡rpd ‡qbib ‡tUS fed doc